Home

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

Antibodies

Chemical Structure Cat. No. Product Name CAS No.
Etanercept Chemical Structure
BCP12862 Etanercept 185243-69-0
Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.
Tremelimumab Chemical Structure
BCP30223 Tremelimumab 745013-59-6
Tremelimumab is a fully human monoclonal antibody against CTLA-4. It is an immune checkpoint blocker.
Abatacept Chemical Structure
BCP30221 Abatacept 332348-12-6
Abatacept is a fusion protein composed of the extracellular domain of CTLA-4 with the hinge, CH2, and CH3 domains of IgG1.
Belatacept Chemical Structure
BCP30222 Belatacept 706808-37-9
Belatacept is a soluble fusion protein, which links the extracellular domain of human cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) to the modified Fc (hinge, CH2, and CH3 domains) portion of human immunoglobulin G1 (IgG1).
Mepolizumab Chemical Structure
BCP13785 Mepolizumab 196078-29-2
Mepolizumab is a humanized monoclonal antibody used for the treatment of severe eosinophilic asthma.
Bimekizumab Chemical Structure
BCP30093 Bimekizumab 1418205-77-2
Bimekizumab is a monoclonal antibody that is being investigated for ankylosing spondylitis and psoriasis.
Romosozumab Chemical Structure
BCP29946 Romosozumab 909395-70-6
Romosozumab is a humanized monoclonal antibody against sclerostin, an inhibitor of osteoblastic activity.
Obinutuzumab Chemical Structure
BCP25211 Obinutuzumab 949142-50-1
Obinutuzumab (called afutuzumab until 2009,originally GA101) is a humanized anti-CD20 monoclonal antibody as a cancer treatment.
Secukinumab Chemical Structure
BCP26257 Secukinumab 875356-43-7
Secukinumab is a human IgG1κ monoclonal antibody that binds to the protein interleukin (IL)-17A.
Daratumumab Chemical Structure
BCP23828 Daratumumab 945721-28-8
Daratumumab is an IgG1k monoclonal antibody directed against CD38.
123下一页末页共 43 条记录 1 / 5 页 
0086-13720134139